Click on image to view larger version.

Figure 4 Correlation between changes in the ¹²³I-meta-iodobenzylguandine scintigraphic findings and the percent change in brain natriuretic peptide (BNP) from baseline to six months in patients receiving candesartan. Delta TDS = total defect score value after six months – pretreatment TDS value; delta H/M ratio = heart/mediastinum count ratio after six months – pretreatment H/M ratio; delta WR = washout rate after six months – pretreatment WR.